|
|
COVID-19相关性肾损伤研究进展
|
Abstract:
自2019年12月发现新型冠状病毒肺炎(Corona Virus Disease 2019, COVID-19)以来，该病以其高传染性、高致病率，成为威胁全球的突发公共卫生事件。COVID-19造成的相关性肾损伤已在临床上受到广泛关注，为此我们通过对COVID-19相关性肾损伤的流行病学特征、致病机制、临床防治处理等方面进行阐述，以供临床研究决策，改善患者临床预后。
Since the discovery of COVID-19 (corona virus disease 2019, COVID-19) in December 2019, the dis-ease has become a public health emergency threatening with high infectivity and high morbidity. The correlation of kidney injury caused by COVID-19 has received wide clinical attention. For this reason, we expounded the epidemiological characteristics, pathogenic mechanisms and clinical prevention and treatment of COVID-19 related kidney injury, in order to provide decisions for clini-cal research, and improve the clinical prognosis of patients.
| [1] | World Health Organization (2022) COVID-19 Weekly Epidemiological Update, Edition 122, 14 December 2022.
https://apps.who.int/iris/handle/10665/365352 |
| [2] | 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第九版) [EB/OL].
http://www.nhc.gov.cn/yzygj/s7653p/202203/
b74ade1ba4494583805a3d2e40093d88/files/
ef09aa4070244620b010951b088b8a27.pdf, 2022-03-15. |
| [3] | Puelles, V.G., Lütgehetmann, M., Lindenmeyer, M.T., et al. (2020) Multiorgan and Renal Tropism of SARS-CoV-2. New England Journal of Medicine, 383, 590-592. https://doi.org/10.1056/NEJMc2011400 |
| [4] | Liakopoulos, V., Roumeliotis, S., Papachristou, S. and Papanas, N. (2022) COVID-19 and the Kidney: Time to Take a Closer Look. International Urology and Nephrology, 54, 1053-1057. https://doi.org/10.1007/s11255-021-02976-7 |
| [5] | Rothan, H.A. and Byrareddy, S.N. (2020) The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. Journal of Autoimmunity, 109, Article ID: 102433. https://doi.org/10.1016/j.jaut.2020.102433 |
| [6] | Zhu, N., Zhang, D., Wang, W., et al. (2020) A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 382, 727-733. https://doi.org/10.1056/NEJMoa2001017 |
| [7] | Zheng, X., Yang, H., Li, X., et al. (2020) Prevalence of Kidney In-jury and Associations with Critical Illness and Death in Patients with COVID-19. Clinical Journal of the American Soci-ety of Nephrology, 15, 1549-1556.
https://doi.org/10.2215/CJN.04780420 |
| [8] | Jafari-Oori, M., Fiorentino, M., Castellano, G.,
et al. (2021) Acute Kidney Injury and Covid-19:
A Scoping Review and Meta-Analysis. In: Guest, P.C.,
Eds., Clinical, Biological and Mo-lecular Aspects of
COVID-19. Advances in Experimental Medicine and
Biology, Vol. 1321, Springer, Cham, 309-324.
https://doi.org/10.1007/978-3-030-59261-5_28 |
| [9] | Chen, Z., Gao, C., Yu, H., et al. (2021) Hypophosphatemia Is an Independent Risk Factor for AKI among Hospitalized Patients with COVID-19 Infection. Renal Failure, 43, 1329-1337. https://doi.org/10.1080/0886022X.2021.1979039 |
| [10] | Silver, S.A., Beaubien-Souligny, W., Shah, P.S., et al. (2021) The Prevalence of Acute Kidney Injury in Patients Hospitalized with COVID-19 Infection: A Systematic Review and Meta-Analysis. Kidney Medicine, 3, 83-98.
https://doi.org/10.1016/j.xkme.2020.11.008 |
| [11] | Hirsch, J.S., Ng, J.H., Ross, D.W., et al. (2020) Acute Kidney Injury in Patients Hospitalized with COVID-19. Kidney International, 98, 209-218. https://doi.org/10.1016/j.kint.2020.05.006 |
| [12] | Hakroush, S., Tampe, D., Korsten, P. and Tampe, B. (2021) Impact of the COVID-19 Pandemic on Kidney Diseases Requiring Renal Biopsy: A Single Center Observational Study. Fron-tiers in Physiology, 12, Article 649336.
https://doi.org/10.3389/fphys.2021.649336 |
| [13] | Gross, O., Moerer, O., Rauen, T., et al. (2021) Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study. Journal of Clinical Medicine, 10, Article No. 3049. https://doi.org/10.3390/jcm10143049 |
| [14] | Kant, S., Menez, S.P., Hanouneh, M., et al. (2020) The COVID-19 Nephrology Compendium: AKI, CKD, ESKD and Trans-plantation. BMC Nephrology, 21, Article No. 449. https://doi.org/10.1186/s12882-020-02112-0 |
| [15] | Chan, L., Chaudhary, K., Saha, A., et al. (2021) AKI in Hospitalized Patients with COVID-19. Journal of the American Society of Nephrology, 32, 151-160. https://doi.org/10.1681/ASN.2020050615 |
| [16] | Dessie, Z.G. and Zewotir, T. (2021) Mortality-Related Risk Factors of COVID-19: A Systematic Review and Meta-Analysis of 42 Studies and 423, 117 Pa-tients. BMC Infectious Diseases, 21, Article No. 855.
https://doi.org/10.1186/s12879-021-06536-3 |
| [17] | Su, H., Yang, M., Wan, C., et al. (2020) Renal Histopathological Analysis of 26 Postmortem Findings of Patients with COVID-19 in China. Kidney International, 98, 219-227. https://doi.org/10.1016/j.kint.2020.04.003 |
| [18] | Larsen, C.P., Bourne, T.D., Wilson, J.D., Saqqa, O.
and Sharshir, M.A. (2020) Collapsing Glomerulopathy
in a Patient with COVID-19. Kidney International Reports,
5, 935-939. https://doi.org/10.1016/j.ekir.2020.04.002 |
| [19] | Deshmukh, S., Zhou, X.J. and Hiser, W. (2020) Collapsing Glo-merulopathy in a Patient of Indian Descent in the Setting of COVID-19. Renal Failure, 42, 877-880. https://doi.org/10.1080/0886022X.2020.1811122 |
| [20] | Kaye, A.D., Okeagu, C.N., Tortorich, G., et al. (2021) COVID-19 Impact on the Renal System: Pathophysiology and Clinical Outcomes. Best Practice & Research Clinical Anaesthesiology, 35, 449-459.
https://doi.org/10.1016/j.bpa.2021.02.004 |
| [21] | Chen, N., Zhou, M., Dong, X., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet, 395, 507-513.
https://doi.org/10.1016/S0140-6736(20)30211-7 |
| [22] | Cheng, Y., Luo, R., Wang, K., et al. (2020) Kidney Disease Is Associated with in-Hospital Death of Patients with COVID-19. Kidney International, 97, 829-838. https://doi.org/10.1016/j.kint.2020.03.005 |
| [23] | Vaidya, T., Nanivadekar, A. and Patel, R. (2021) Imaging Spectrum of Abdominal Manifestations of COVID-19. World Journal of Radiology, 13, 157-170. https://doi.org/10.4329/wjr.v13.i6.157 |
| [24] | Singh, P., Singh, S.P., Verma, A.K., Raju, S.N. and Parihar, A. (2021) A Systematic Review of Abdominal Imaging Findings in COVID-19 Patients. Visceral Medicine, 37, 521-532. https://doi.org/10.1159/000518473 |
| [25] | Pei, G., Zhang, Z., Peng, J., et al. (2020) Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. Journal of the American Society of Nephrology, 31, 1157-1165. https://doi.org/10.1681/ASN.2020030276 |
| [26] | Xiao, L., Sakagami, H. and Miwa, N. (2020) ACE2: The Key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? Viruses, 12, Article No. 491.
https://doi.org/10.3390/v12050491 |
| [27] | Pan, X.-W., Xu, D., Zhang, H., et al. (2020) Identification of a Potential Mechanism of Acute Kidney Injury during the COVID-19 Outbreak: A Study Based on Single-Cell Transcriptome Analysis. Intensive Care Medicine, 46, 1114-1116.
https://doi.org/10.1007/s00134-020-06026-1 |
| [28] | Pecly, I.M.D., Azevedo, R.B., Muxfeldt, E.S., et al. (2021) A Review of Covid-19 and Acute Kidney Injury: From Pathophysiology to Clinical Results. Brazilian Journal of Nephrol-ogy, 43, 551-571.
https://doi.org/10.1590/2175-8239-JBN-2020-0204 |
| [29] | Salvadori, M., Rosso, G. and Bertoni, E. (2015) Update on Ischemia-Reperfusion Injury in Kidney Transplantation: Pathogenesis and Treatment. World Journal of Transplanta-tion, 5, 52-67. https://doi.org/10.5500/wjt.v5.i2.52 |
| [30] | Shukla, A.K. and Banerjee, M. (2021) Angioten-sin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. High Blood Pressure & Cardiovascular Prevention, 28, 129-139.
https://doi.org/10.1007/s40292-021-00439-9 |
| [31] | Thomas, G. (2020) Renin-Angiotensin System Inhibitors in COVID-19. Cleveland Clinic Journal of Medicine.
https://doi.org/10.3949/ccjm.87a.ccc009 |
| [32] | Liu, J., Li, S., Liu, J., et al. (2020) Longitudinal Characteristics of Lymphocyte Responses and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients. EBioMedicine, 55, Article ID: 102763.
https://doi.org/10.1016/j.ebiom.2020.102763 |
| [33] | Pan, P., Du, X., Zhou, Q., et al. (2022) Characteristics of Lym-phocyte Subsets and Cytokine Profiles of Patients with COVID-19. Virology Journal, 19, Article No. 57. https://doi.org/10.1186/s12985-022-01786-2 |
| [34] | Mulchandani, R., Lyngdoh, T. and Kakkar, A.K. (2021) Deci-phering the COVID-19 Cytokine Storm: Systematic Review and Meta-Analysis. European Journal of Clinical Investiga-tion, 51, e13429. https://doi.org/10.1111/eci.13429 |
| [35] | Leisman, D.E., Ronner, L., Pinotti, R., et al. (2020)
Cyto-kine Elevation in Severe and Critical COVID-19:
A Rapid Systematic Review, Meta-Analysis, and
Comparison with Other Inflammatory Syndromes.
The Lancet Respiratory Medicine, 8, 1233-1244. https://doi.org/10.1016/S2213-2600(20)30404-5 |
| [36] | Gradin, A., Andersson, H., Luther, T., et al. (2021) Urinary Cytokines Correlate with Acute Kidney Injury in Critically Ill COVID-19 Patients. Cytokine, 146, Article ID: 155589. https://doi.org/10.1016/j.cyto.2021.155589 |
| [37] | Jamaly, S., Tsokos, M.G., Bhargava, R., et al. (2021) Complement Activation and Increased Expression of Syk, Mucin-1 and CaMK4 in Kidneys of Patients with COVID-19. Clinical Im-munology, 229, Article ID: 108795.
https://doi.org/10.1016/j.clim.2021.108795 |
| [38] | Darmon, M., Schortgen, F., Leon, R., et al. (2009) Impact of Mild Hypoxemia on Renal Function and Renal Resistive Index during Mechanical Ventilation. Intensive Care Medicine, 35, 1031-1038.
https://doi.org/10.1007/s00134-008-1372-5 |
| [39] | Mitra, S., Ling, R.R., Yang, I.X., et al. (2021) Severe COVID-19 and Coagulopathy: A Systematic Review and Meta-Analysis. Annals of the Academy of Medicine of Singapore, 50, 325-335.
https://doi.org/10.47102/annals-acadmedsg.2020420 |
| [40] | Schneider, J., Jaenigen, B., Wagner, D., et al. (2021) Therapy with Lopinavir/Ritonavir and Hydroxychloroquine Is Associated with Acute Kidney Injury in COVID-19 Pa-tients. PLOS ONE, 16, e249760.
https://doi.org/10.1371/journal.pone.0249760 |
| [41] | Nguyen, H., Salkeld, J., Agarwal, S. and Goodman, A. (2021) Compassionate Use of REGN-COV2 in the Treatment of COVID-19 in a Patient with Impaired Humoral Immunity. Clinical Infection in Practice, 12, Article ID: 100089.
https://doi.org/10.1016/j.clinpr.2021.100089 |
| [42] | Shazley, O., Shazley, A. and Alshazley, M. (2022)
Acute Bacte-rial Hemorrhagic Pyelonephritis in a
COVID-19 Patient with a History of
Hypothyroidism: A Case Report. Cureus, 14, e21730. https://doi.org/10.7759/cureus.21730 |
| [43] | Mohamadi, Y.Z. and Najafi, H. (2021) Kidney Injury in COVID-19 Patients, Drug Development and Their Renal Complications: Review Study. Biomedicine & Pharmacother-apy, 142, Article ID: 111966.
https://doi.org/10.1016/j.biopha.2021.111966 |
| [44] | 中华人民共和国国家卫生健康委员会. 关于将阿兹夫定片纳入新型冠状病毒肺炎诊疗方案的通知[EB/OL].
http://www.nhc.gov.cn/xcs/gzzcwj/202208/33e3ff4308b4446796c3f315601d436f.shtml, 2022-08-09. |
| [45] | Lamontagne, F., Agarwal, A., Rochwerg, B., et al. (2020) A Living WHO Guideline on Drugs for Covid-19. BMJ, 370, Article No. m3379. https://doi.org/10.1136/bmj.m3379 |
| [46] | (2022) Update to Living WHO Guideline on Drugs for Covid-19. BMJ, 377, Article No. o1005.
https://doi.org/10.1136/bmj.o1005 |
| [47] | 王蒙蒙, 任戎, 李丽, 等. 糖皮质激素在重型及危重型COVID-19患者中的应用进展[J]. 中南药学, 2022, 20(7): 1605-1609. |
| [48] | 王肇辉, 解红霞. 糖皮质激素的药理作用及在肾脏病中的应用与进展[J]. 医学综述, 2017, 23(9): 1815-1820. |
| [49] | Kumar, S., Allen, D.A., Kieswich, J.E., et al. (2009) Dexamethasone Ameliorates Renal Ischemia-Reperfusion Injury. Journal of the American Society of Nephrology, 20, 2412-2425. https://doi.org/10.1681/ASN.2008080868 |
| [50] | Sayed, Z.A. and Sayed, S.S. (2020) A Comparative Study of the Use of Dexamethasone, N-acetyl Cysteine, and
Theophylline to Ameliorate Renal Ischemia-Reperfusion
In-jury in Experimental Rat Models: A Biochemical and Immuno-histochemical Approach. Saudi Journal of Kidney
Dis-eases and Transplantation, 31, 982-997.
https://doi.org/10.4103/1319-2442.301203 |
| [51] | 赵籥陶, 黄慈波. 糖皮质激素的合理使用[J]. 临床药物治疗杂志, 2010, 8(1): 23-28. |
| [52] | Shu, Z., Wu, P., Qian, Q., et al. (2022)
Effectiveness and Controversy of Convalescent
Plasma Therapy for Coronavirus Disease 2019
Patients. Infectious Diseases & Immunity, 2, 49-54. https://doi.org/10.1097/ID9.0000000000000033 |
| [53] | Ozdemir, O. (2021) Perplexing Issues for Convalescent Im-mune Plasma Therapy in COVID-19. Northern Clinics of Istanbul, 8, 634-643. https://doi.org/10.14744/nci.2021.73604 |
| [54] | 朱丽媛, 叶生亮, 马莉, 等. 静注入免疫球蛋白在其适应证及超适应证中应用的研究进展[J]. 中国生物制品学杂志, 2022, 35(10): 1249-1256. |
| [55] | Cortegiani, A., Ippolito, M., Greco, M., et al. (2021) Rationale and Evidence on the Use of Tocilizumab in COVID-19: A Systematic Review. Pul-monology, 27, 52-66. https://doi.org/10.1016/j.pulmoe.2020.07.003 |
| [56] | 中华医学会肾脏病学分会, 中国研究型医院学会肾脏病学专业委员会. 特殊血液净化技术应用于重症新型冠状病毒肺炎的专家共识[J]. 中华内科杂志, 2020, 59(11): 847-853. |
| [57] | Vinsonneau, C., Camus, C., Combes, A., et al. (2006) Continuous Venovenous Hae-modiafiltration versus Intermittent Haemodialysis for Acute Renal Failure
in Patients with Multiple-Organ Dysfunction Syndrome:
A Multicentre Randomised Trial. Lancet, 368, 379-385. https://doi.org/10.1016/S0140-6736(06)69111-3 |
| [58] | Yang, X., Tian, S. and Guo, H. (2021) Acute Kidney Injury and Renal Replacement Therapy in COVID-19 Patients: A Systematic Review and Meta-Analysis. International Im-munopharmacology, 90, Article ID: 107159.
https://doi.org/10.1016/j.intimp.2020.107159 |
| [59] | 滕杰, 邹建洲, 丁小强. 连续性肾脏替代治疗在新型冠状病毒肺炎救治中的应用[J]. 上海医学, 2020, 43(9): 528-533. |
| [60] | 钱倩倩, 卢志武, 王静, 郭婷婷, 李争, 舒占钧. 97例新冠肺炎中西医结合治疗经验总结[J].中国医药导刊, 2021, 23(2): 81-85. |
| [61] | 仝小林, 李修洋, 赵林华, 等. 从“寒湿疫”角度探讨新型冠状病毒肺炎的中医药防治策略[J]. 中医杂志, 2020, 61(6): 465-470. |
| [62] | 高树明, 马英, 杨丰文, 等. 张伯礼: 中医药在防治新型冠状病毒肺炎全过程发挥作用[J]. 天津中医药, 2020, 37(2): 121-124. |
| [63] | 中国中西医结合学会. 新型冠状病毒肺炎中西医结合防治专家共识[J]. 中国中西医结合杂志, 2020, 40(12): 1413-1423. |
| [64] | Kim, T., Min, K.I., Yang, J.S., et al. (2022) Relative Infectivity of the SARS-CoV-2 Omicron Variant in Human Alveolar Cells. BioRxiv Preprint. https://doi.org/10.1101/2022.04.13.486321 |
| [65] | Akkiz, H. (2022) The Biological Functions and Clinical Signifi-cance of SARS-CoV-2 Variants of Corcern. FFrontiers in Medicine, 9, Article 849217. https://doi.org/10.3389/fmed.2022.849217 |
| [66] | Xia, S., Wang, L., Zhu, Y., Lu, L. and Jiang,
S. (2022) Origin, Vi-rological Features, Immune
Evasion and Intervention of SARS-CoV-2 Omicron
Sublineages. Signal Transduction and Targeted
Therapy, 7, Article No. 241.
https://doi.org/10.1038/s41392-022-01105-9 |
| [67] | Klomjit, N., Alexander, M.P., Fervenza, F.C., et al. (2021) COVID-19 Vaccination and Glomerulonephritis. Kidney International Reports, 6, 2969-2978. https://doi.org/10.1016/j.ekir.2021.09.008 |
| [68] | Li, Y., Rao, M. and Xu, G. (2022) New-Onset Acute Kidney Dis-ease Post COVID-19 Vaccination. Vaccines, 10, Article No. 742. https://doi.org/10.3390/vaccines10050742 |
| [69] | Uchiyama, Y., Fukasawa, H., Ishino, Y., et al. (2022) Sibling Cas-es of Gross Hematuria and Newly Diagnosed IgA Nephropathy Following SARS-CoV-2 Vaccination. BMC Nephrolo-gy, 23, Article No. 216.
https://doi.org/10.1186/s12882-022-02843-2 |
